Address:
Tel:
Web: http://www.gouvernement.fr/gouvernement/valerie-pecresse
A graduate of the Ecole des Hautes Etudes Commerciales (HEC) in 1988
Graduated from the Ecole Nationale d’Administration (ENA), promotion Condorcet
Valérie Pécresse has been then Minister of Higher Education and Research for France since May 2007
Career
Consultant in charge of studies, foresight and information technology to the presidency of the Republic, from 1998 to 2002
Listeners to the Council of State, from 1995 to 1998
** Master of the applications to the Council of State
Elective offices
Deputy of Yvelines, since 2002 Member of the Cultural Affairs Committee, member of the delegation of the National Assembly on women’s rights and equal opportunities for women. Reelected in 2007
Regional Advisor of Ile-de-France
Corporate Functions
Minister of Higher Education and Research, since May 2007
Minister of Higher Education and Research, since May 2007
Political Functions
Policy Advisor to the UMP, since 2008
Assistant Secretary General of the UMP, in charge of studies and the Centre for Policy Studies
Spokesperson of the UMP
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
The President of Fefis, and the recently elected President of Medicen Paris Region, a Paris-based business cluster, talks about the need to build the future of the French health economy, not…
The director of GEMME reveals how the French generics market is young in comparison to other European countries – where generics were on the market twenty years before they became…
The Chairman & CEO of DBV Technologies reveals how they have developed a new therapeutic method and new technology in the form of a patch to treat various allergies. DBV received…
The President of Cristers discusses the history of generic drugs in France and what steps can be taken to increase generics penetration, while also outlining the ‘cooperative’ business model behind…
Yves Bur reveals how the motivation behind his political engagement has been to raise awareness around the importance of improving the social security system. Bur also explains why having a…
The General Manager of LEEM talks about the association’s strategy based on three key points, innovation, attractiveness and efficiency; how the Mediator affair has placed a question mark on the…
CPhI Worldwide 2014, held this year in Paris, was the largest ever event held by the organizers, with more than 36,000 attendees and 2,500 exhibitors. PharmaBoardroom was a media partner…
Nycomed lost an important patent with Pantoprazole in the middle of 2009, which has undoubtedly warranted some restructuring. What has been the impact of this loss on business in France,…
BMS recently announced divesting from their facilities in Epernon and Meymac but at the same time reinforcing manufacturing in Agen. Could you speak to strategy of this restructuring within France…
You worked for many years in emerging markets, especially in Latin America, but also in neighbor countries such as Spain. How these previous experiences in very different markets can now…
In the wake of the most recent CSIS meeting, LFB and Sanofi-Aventis announced the intention to collaborate in bioproduction. What are the terms to this agreement and what are the…
We have had the chance to interview a number of Teva’s subsidiaries in Europe, and witnessed how each of them has dealt with the strong transformations that the group has…
See our Cookie Privacy Policy Here
